SEC Filing Summary: Revelation Biosciences, Inc. (REVB)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Revelation Biosciences, Inc. on June 24, 2024. The filing addresses a specific corporate event regarding the adjustment of exercise prices for outstanding Class C and Class D Common Stock Purchase Warrants.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on warrant mechanics and does not contain financial statement data.
Material Changes
The primary material change reported is the adjustment of the Exercise Price for two classes of warrants pursuant to their respective agreements:
- Class C Warrants (CUSIP: 76135L408): Adjusted to be exercisable for a 1/30th of a share of common stock at an exercise price of $2.39 per share.
- Class D Warrants (CUSIP: 76135L143): Adjusted to be exercisable for one full share of common stock at an exercise price of $2.39 per share.
Until the Depository Trust Corporation (DTC) system reflects these adjustments, warrant holders cannot exercise through the standard DTC process. Instead, holders must submit a Notice of Warrant Exercise directly to the Warrant Agent, Continental Stock Transfer & Trust Company.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The primary operational contingency noted is the temporary inability to process warrant exercises via DTC until the system updates. Settlement of exercised warrants will be handled via wire transfer and DWAC instructions provided by the Warrant Agent upon receipt of the exercise notice.
Investor Verification Checklist
- Verify the updated exercise price of $2.39 per share for both Class C and Class D warrants.
- Confirm the specific share fraction for Class C warrants (1/30th of a share) versus Class D warrants (1 full share).
- Check the status of the DTC system update to determine if manual exercise via the Warrant Agent is still required.
- Review the attached Exhibit 99.1 (Notice of Warrant Exercise) for the correct format if manual exercise is necessary.